Lorazepam treatment may be linked to worse outcomes for pancreatic cancer patients

Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to results published in Clinical Cancer Research.

Leave A Comment

Your email address will not be published. Required fields are marked *